News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
214,382 Results
Type
Article (10158)
Company Profile (58)
Press Release (204165)
Section
Business (70579)
Career Advice (269)
Deals (12380)
Drug Delivery (13)
Drug Development (28003)
Employer Resources (22)
FDA (5824)
Job Trends (5578)
News (116512)
Policy (10830)
Tag
Academia (1116)
Academic (1)
Accelerated approval (8)
Adcomms (1)
Allergies (61)
Alliances (11828)
ALS (39)
Alzheimer's disease (605)
Antibody-drug conjugate (ADC) (91)
Approvals (6024)
Artificial intelligence (87)
Autoimmune disease (29)
Automation (6)
Bankruptcy (82)
Best Places to Work (4970)
BIOSECURE Act (1)
Biosimilars (51)
Biotechnology (34)
Bladder cancer (69)
Brain cancer (20)
Breast cancer (238)
Cancer (1552)
Cardiovascular disease (121)
Career advice (242)
Career pathing (4)
CAR-T (65)
CDC (9)
Cell therapy (167)
Cervical cancer (16)
Clinical research (24982)
Collaboration (293)
Company closure (2)
Compensation (154)
Complete response letters (11)
COVID-19 (876)
CRISPR (11)
C-suite (107)
Cystic fibrosis (41)
Data (2328)
Depression (29)
Diabetes (168)
Diagnostics (3113)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (41)
Drug pricing (24)
Drug shortages (3)
Duchenne muscular dystrophy (77)
Earnings (46788)
Editorial (8)
Employer branding (7)
Employer resources (18)
Events (30577)
Executive appointments (125)
FDA (6966)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (259)
Gene editing (35)
Generative AI (8)
Gene therapy (146)
GLP-1 (319)
Government (1647)
Grass and pollen (3)
Guidances (325)
Healthcare (8483)
HIV (22)
Huntington's disease (8)
IgA nephropathy (24)
Immunology and inflammation (72)
Immuno-oncology (8)
Indications (31)
Infectious disease (971)
Inflammatory bowel disease (49)
Inflation Reduction Act (2)
Influenza (31)
Intellectual property (51)
Interviews (42)
IPO (7492)
IRA (3)
Job creations (822)
Job search strategy (204)
Kidney cancer (5)
Labor market (22)
Layoffs (200)
Leadership (4)
Legal (2478)
Liver cancer (19)
Longevity (3)
Lung cancer (252)
Lymphoma (170)
Machine learning (6)
Management (6)
Manufacturing (119)
MASH (68)
Medical device (6855)
Medtech (6868)
Mergers & acquisitions (5181)
Metabolic disorders (386)
Multiple sclerosis (71)
NASH (9)
Neurodegenerative disease (84)
Neuropsychiatric disorders (12)
Neuroscience (952)
NextGen: Class of 2025 (2626)
Non-profit (1934)
Now hiring (7)
Obesity (146)
Opinion (62)
Ovarian cancer (46)
Pain (62)
Pancreatic cancer (60)
Parkinson's disease (82)
Partnered (9)
Patents (94)
Patient recruitment (84)
Peanut (28)
People (11832)
Pharmaceutical (16)
Pharmacy benefit managers (7)
Phase I (6716)
Phase II (10532)
Phase III (9745)
Pipeline (2100)
Policy (31)
Postmarket research (1040)
Preclinical (2139)
Press Release (12)
Prostate cancer (76)
Psychedelics (5)
Radiopharmaceuticals (75)
Rare diseases (221)
Real estate (1557)
Recruiting (7)
Regulatory (7953)
Reports (21)
Research institute (959)
Resumes & cover letters (32)
Rett syndrome (15)
RNA editing (2)
RSV (37)
Schizophrenia (64)
Series A (39)
Series B (20)
Service/supplier (4)
Sickle cell disease (23)
Special edition (9)
Spinal muscular atrophy (63)
Sponsored (10)
Startups (797)
Stomach cancer (3)
Supply chain (21)
Tariffs (15)
The Weekly (5)
Vaccines (340)
Venture capital (13)
Weight loss (97)
Women's health (13)
Worklife (2)
Date
Today (30)
Last 7 days (201)
Last 30 days (888)
Last 365 days (10216)
2025 (9905)
2024 (11810)
2023 (13217)
2022 (14854)
2021 (16747)
2020 (15781)
2019 (13222)
2018 (29102)
2017 (14297)
2016 (7756)
2015 (9622)
2014 (6748)
2013 (4998)
2012 (5269)
2011 (5827)
2010 (5165)
Location
Africa (208)
Alabama (14)
Alaska (1)
Arizona (80)
Arkansas (3)
Asia (13168)
Australia (1673)
California (3211)
Canada (1109)
China (362)
Colorado (133)
Connecticut (151)
Delaware (135)
Europe (28693)
Florida (482)
Georgia (152)
Idaho (20)
Illinois (251)
India (19)
Indiana (220)
Iowa (3)
Japan (133)
Kansas (55)
Kentucky (9)
Louisiana (15)
Maine (30)
Maryland (411)
Massachusetts (2208)
Michigan (69)
Minnesota (185)
Mississippi (2)
Missouri (28)
Montana (6)
Nebraska (4)
Nevada (34)
New Hampshire (18)
New Jersey (1257)
New Mexico (3)
New York (997)
North Carolina (443)
North Dakota (1)
Northern California (1653)
Ohio (66)
Oklahoma (1)
Oregon (8)
Pennsylvania (831)
Puerto Rico (2)
Rhode Island (14)
South America (305)
South Carolina (11)
South Dakota (1)
Southern California (1210)
Tennessee (40)
Texas (502)
United States (12205)
Utah (119)
Vermont (1)
Virginia (49)
Washington D.C. (27)
Washington State (243)
West Virginia (1)
Wisconsin (20)
214,382 Results for "18".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
What Trends Are Boosting the 18.9% CAGR in the CGT Pharmaceuticals Market?
December 4, 2025
·
1 min read
Press Releases
NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
December 9, 2025
·
5 min read
Press Releases
CereMark Pharma Begins Phase III Trial of F-18 Flornaptitril, a Novel Diagnostic Radiopharmaceutical Focused on Neurodegeneration
F-18 Flornaptitril was designed to simultaneously detect tau aggregates and beta-amyloid plaques within a single PET scan
July 10, 2025
·
1 min read
Antibody-drug conjugate (ADC)
Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition
Only one clinical-stage asset from the ProfoundBio acquisition remains in development: The antibody-drug conjugate Rina-S, in late-stage studies for ovarian and endometrial cancer.
November 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Solana Company to Release Third Quarter Operating Results on November 18, 2025
November 13, 2025
·
1 min read
Press Releases
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
November 19, 2025
·
3 min read
Press Releases
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
November 13, 2025
·
9 min read
Press Releases
Plasmid DNA Manufacturing Market Poised to Surge to USD 18.11 Billion by 2034 at a Remarkable 21.05% CAGR
December 1, 2025
·
1 min read
Press Releases
Pfizer Canada Announces Health Canada Approval of ABRYSVO® for Adults 18+
October 22, 2025
·
2 min read
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - November 18, 2025
November 19, 2025
·
4 min read
1 of 21,439
Next
